Media presence is a key part of making society aware of developments in biotechnology and its benefits. AseBio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at AseBio.
Studies have shown that the CECT5713 strain of Lactobacillus Salivarius allowed pregnancies to be 66% effective in women with infertility of unknown cause
The Barcelona Science Park kicks off the 17th Batx2Lab, a pioneering programme which has inspired the STEM talent of more than 700 young people
VIVEbiotech, S.L. announces a collaboration with Xyphos Biosciences for the development its CAR-T™ cell therapy for people with hematological cancer.
“Actualidad Economica” is the dean magazine of the Spanish economic press, founded in 1958
Given the situation caused by the Covid-19 pandemic, with the recommendations of healthcare authorities in mind and foreseeing the situations that may arise over the remainder of 2020, AseBio decided to postpone the event to 2021
CIR certificate is extended for a four-year period between 2020-2024
The three candidates inhibit the main protease of SARS-CoV-2 and therefore the replication of the virus. Clinical studies with the three candidates can be initiated immediately
3P Biopharmaceuticals together with the Swedish biotechnology company Intervacc AB and LIOF-Pharma (previously Praxis Pharmaceutical), completed the manufacturing process for the vaccine against equine strangles called Strangvac.
XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery will be held from January 22-24th, 2020 at the University of Santiago de Compostela